Bilan d'une année d'utilisation de la mifépristone pour les interruptions de grossesse = First experiences with mifepristone in pregnancy interruptionsSCHNEIDER, N; VIARDOT, C; WIRTHNER, D et al.Médecine et hygiène. 2001, Vol 59, Num 2362, pp 1872-1877, issn 0025-6749, 4 p.Article

L'IVG médicamenteuse fait école en villeMIGNOT, Sandra.L'INFIRMIERE MAGAZINE. 2008, Num 240, pp 42-43, issn 0981-0560, 2 p.Article

The use of mifepristone in the treatment of neuropsychiatric disordersDEBATTISTA, Charles; BELANOFF, Joseph.Trends in endocrinology and metabolism. 2006, Vol 17, Num 3, pp 117-121, issn 1043-2760, 5 p.Article

Levonorgestrel and mifepristone in emergency contraceptionVON HERTZEN, Helena; PIAGGIO, Gilda.Steroids. 2003, Vol 68, Num 10-13, pp 1107-1113, issn 0039-128X, 7 p.Conference Paper

Analysis of failure in medical abortionWINIKOFF, B; ELLERTSON, C; CLARK, S et al.Contraception (Stoneham). 1996, Vol 54, Num 6, pp 323-327, issn 0010-7824Article

An international study on the acceptability of a once-a-month pillGLASIER, A. F; SMITH, K. B; CHENG, L et al.Human reproduction (Oxford. Print). 1999, Vol 14, Num 12, pp 3018-3022, issn 0268-1161Article

Antiglucocorticoid therapies in major depression : A reviewMURPHY, B. E. P.Psychoneuroendocrinology. 1997, Vol 22, pp S125-S132, issn 0306-4530, SUP1Conference Paper

Transvaginal ultrasound and the success of medical abortionEDELMAN, A; THOMAS, L; JENSEN, J et al.International journal of gynaecology and obstetrics. 2004, Vol 85, Num 1, pp 62-63, issn 0020-7292, 2 p.Article

Les antiprogestérones = AntiprogestinsSITRUK-WARE, R.La Presse médicale (1983). 1999, Vol 28, Num 38, pp 2123-2131, issn 0755-4982Article

Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate usersAIMIN LI; FELIX, Juan C; WANGRONG YANG et al.Fertility and sterility. 2008, Vol 90, Num 3, pp 872-875, issn 0015-0282, 4 p.Article

Mifepristone and prostaglandin for termination of pregnancy : contraindications for use, reasons and rationaleDAVEY, Angela.Contraception (Stoneham). 2006, Vol 74, Num 1, pp 16-20, issn 0010-7824, 5 p.Article

Mifépristone à la dose de 100 mg dans les avortements médicamenteux = Mifepristone 100mg for early medical abortionJERBI, M; HIDAR, S; SAHRAOUI, W et al.Journal de gynécologie obstétrique et biologie de la reproduction. 2005, Vol 34, Num 3, pp 257-261, issn 0368-2315, 5 p., CAH1Article

A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortionCREININ, Mitchell D; FOX, Michelle C; TEAL, Stephanie et al.Obstetrics and gynecology (New York. 1953). 2004, Vol 103, Num 5, pp 851-859, issn 0029-7844, 9 p., 2Article

Noncompliance among a group of women using a novel method of contraceptionHAPANGAMA, Dharani K; GLASIER, Anna F; BAIRD, David T et al.Fertility and sterility. 2001, Vol 76, Num 6, pp 1196-1201, issn 0015-0282Article

Pharmacokinetics of mifepristone after low oral dosesKEKKONEN, R; HEIKINHEIMO, O; MANDELIN, E et al.Contraception (Stoneham). 1996, Vol 54, Num 4, pp 229-234, issn 0010-7824Article

Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancyPERUSQUIA, Mercedes; ESPINOZA, Julia; NAVARRETE, Erika et al.Steroids. 2009, Vol 74, Num 10-11, pp 825-831, issn 0039-128X, 7 p.Article

Fatal infections associated with mifepristone-induced abortionGREENE, Michael F.The New England journal of medicine. 2005, Vol 353, Num 22, pp 2317-2318, issn 0028-4793, 2 p.Article

Mifépristone et grossesse : Les faits maquants 2004 = Mifepristone and pregnancyLa Revue Prescrire. 2004, Vol 24, Num 255, pp 754-755, issn 0247-7750, 2 p.Conference Paper

WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: EfficacyVON HERTZEN, Helena; HONKANEN, Helena; NGUYEN THI NHU NGOC et al.BJOG (Oxford. Print). 2003, Vol 110, Num 9, pp 808-818, issn 1470-0328, 11 p.Article

An effective regimen for early medical abortion : a report of 2000 consecutive casesASHOK, P. W; PENNEY, G. C; FLETT, G. M. M et al.Human reproduction (Oxford. Print). 1998, Vol 13, Num 10, pp 2962-2965, issn 0268-1161Article

Clinical pharmacokinetics of mifepristoneHEIKINHEIMO, O.Clinical pharmacokinetics. 1997, Vol 33, Num 1, pp 7-17, issn 0312-5963Article

Transcriptomic Effects of Tet-On and Mifepristone-lnducible Systems in Mouse LiverREBOREDO, Mercedes; GABRIELA KRAMER, Maria; SMERDOU, Cristian et al.Human gene therapy. 2008, Vol 19, Num 11, pp 1233-1247, issn 1043-0342, 15 p.Article

Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?LEEMAN, Lawrence; ASARIA, Sheemain; ESPEY, Eve et al.Contraception (Stoneham). 2007, Vol 76, Num 2, pp 96-100, issn 0010-7824, 5 p.Article

Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrelCHENG, L; ZHU, H; WANG, A et al.Human reproduction (Oxford. Print). 2000, Vol 15, Num 9, pp 1969-1972, issn 0268-1161Article

Effect of follicular phase administration of mifepristone (RU486) on blastocyst implantation in the rhesus monkeyGHOSH, D; NIHAR RANJAN NAYAK; SENGUPTA, J et al.Contraception (Stoneham). 1997, Vol 56, Num 2, pp 117-122, issn 0010-7824Article